Role of IL-38 and its related cytokines in inflammation

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Yuan, Xianli ^a   Peng, Xiao ^a   Li, Yan ^a   Li, Mingcai ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 36 RECEPTOR ANTAGONIST; INTERLEUKIN 38; INTERLEUKIN 8; UNCLASSIFIED DRUG; IL-38 PROTEIN, HUMAN; IL1RN PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; INTERLEUKIN-36 RECEPTOR, HUMAN;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; CHEMISTRY; PHYSIOLOGY;

ANIMALS; CYTOKINES; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKINS; RECEPTORS, INTERLEUKIN; SIGNAL TRANSDUCTION;

EID: 84926372071     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/807976     Document Type: Article

References (73)

1. C. A. Dinarello, "Interleukin-1 in the pathogenesis and treatment of inflammatory diseases, " Blood, vol. 117, no. 14, pp. 3720-3732, 2011.
2. C. Dinarello, W. Arend, and J. Sims, "IL-1 family nomenclature, " Nature Immunology, vol. 11, article 973, 2010.
3. H. Lin, A. S. Ho, D. Haley-Vicente et al., "Cloning and characterization of IL-1HY2, a novel interleukin-1 family member, " The Journal of Biological Chemistry, vol. 276, no. 23, pp. 20597-20602, 2001.
4. J. T. Bensen, P. A. Dawson, J. C. Mychaleckyj, andD. W. Bowden, "Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14, " Journal of Interferon and Cytokine Research, vol. 21, no. 11, pp. 899-904, 2001.
5. F. L. van de Veerdonk, A. K. Stoeckman, G. Wu et al., "IL-38 binds to the IL-36 receptor and has biological effects onimmune cells similar to IL-36 receptor antagonist, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 8, pp. 3001-3005, 2012.
6. M. J. H. Nicklin, J. L. Barton, M. Nguyen, M. G. FitzGerald, G. W. Duff, and K. Kornman, "A sequence-based map of the nine genes of the human interleukin-1 cluster, " Genomics, vol. 79, no. 5, pp. 718-725, 2002.
7. S. Kumar, P. C. McDonnell, R. Lehr et al., "Identification and initial characterization of four novel members of the interleukin-family, " The Journal of Biological Chemistry, vol. 275, no. 14, pp. 10308-10314, 2000.
8. H. Shen, J. C. Goodall, and J. S. Hill Gaston, "Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis, " Arthritis and Rheumatism, vol. 60, no. 6, pp. 1647-1656, 2009.
9. M. S. Gresnigt and F. L. van de Veerdonk, "Biology of IL-36 cytokines and their role in disease, " Seminars in Immunology, vol. 25, no. 6, pp. 458-465, 2013.
10. H. E. Barksby, S. R. Lea, P. M. Preshaw, and J. J. Taylor, "The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders, " Clinical and Experimental Immunology, vol. 149, no. 2, pp. 217-225, 2007.
11. B. A. Charles, A. Doumatey, H. Huang et al., "The roles of IL-6, IL-10, and IL-1RA in obesity and insulin resistance in African-Americans, " Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 12, pp. E2018-E2022, 2011.
12. M. F. Nold, C. A. Nold-Petry, J. A. Zepp, B. E. Palmer, P. Bufler, and C. A. Dinarello, "IL-37 is a fundamental inhibitor of innate immunity, " Nature Immunology, vol. 11, no. 11, pp. 1014-1022, 2010.
13. V. Carriere, L. Roussel, N. Ortega et al., "IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 1, pp. 282-287, 2007.
14. F. Xu, S. Cheng, and Y. Luo, "DRB1 gene bioinformatics analysis of sheep, " Biotechnology Bulletin, no. 1, pp. 113-118, 2011.
15. N. V. Kumar, M. E. Rani, R. Gunaseeli, N. D. Kannan, andJ. Sridhar, "Modeling and structural analysis of cellulases using Clostridium thermocellum as template, " Bioinformation, vol. 8, no. 22, pp. 1105-1110, 2012.
16. C. Geourjon and G. Deleage, "SOPMA: significant improvements in protein secondary structure prediction by consensus prediction frommultiple alignments, " Computer Applications in the Biosciences, vol. 11, no. 6, pp. 681-684, 1995.
17. S. J. Busfield, C. A. Comrack, G. Yu et al., "Identification and gene organization of three novel members of the IL-1 family on human chromosome 2, " Genomics, vol. 66, no. 2, pp. 213-216, 2000.
18. D. E. Smith, B. R. Renshaw, R. R. Ketchem, M. Kubin, K. E. Garka, and J. E. Sims, "Four new members expand the interleukin-superfamily, " The Journal of Biological Chemistry, vol. 275, no. 2, pp. 1169-1175, 2000.
19. T. T. Chowdhury, S. Arghandawi, J. Brand et al., "Dynamic compression counteracts IL-1 induced inducible nitric oxide synthase and cyclo-oxygenase-2 expression in chondrocyte/ agarose constructs, " Arthritis Research and Therapy, vol. 10, no. 2, article R35, 2008.
20. E. I. Boesen, "Chronic elevation of IL-1 induces diuresis via a cyclooxygenase 2-mediated mechanism, " The American Journal of Physiology-Renal Physiology, vol. 305, no. 2, pp. F189-F198, 2013.
21. L. A. J. ONeill, "The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress, " Immunological Reviews, vol. 226, no. 1, pp. 10-18, 2008.
22. J. E. Towne, K. E. Garka, B. R. Renshaw, G. D. Virca, and J. E. Sims, "Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-βB andMAPKs, "The Journal of Biological Chemistry, vol. 279, no. 14, pp. 13677-13688, 2004.
23. A. Dunne and L. A. J. ONeill, "The interleukin-1 receptor/Tolllike receptor superfamily: signal transduction during inflammation and host defense, " Sciences STKE, vol. 2003, no. 171, p. re3, 2003.
24. C. A. Dinarello, "Immunological and inflammatory functions of the interleukin-1 family, " Annual Review of Immunology, vol. 27, pp. 519-550, 2009.
25. C. Ding, L. Zhao, Y. Sun, L. Li, and Y. Xu, "Interleukin-1 receptor antagonist polymorphism (rs2234663) and periodontitis susceptibility: a meta-analysis, " Archives of Oral Biology, vol. 57, no. 6, pp. 585-593, 2012.
26. R. N. Fichorova, J.-J. Lai, J. L. Schwartz, D. H. Weiner, C. K. Mauck, and M. M. Callahan, "Baseline variation and associations between subject characteristics and five cytokine biomarkers of vaginal safety among healthy non-pregnant women in microbicide trials, " Cytokine, vol. 55, no. 1, pp. 134-140, 2011.
27. H. D. Hosgood, M. P. Purdue, S. S. Wang et al., "A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk, " The British Journal of Haematology, vol. 152, no. 6, pp. 721-726, 2011.
28. H. Xue, B. Lin, P. Ni, H. Xu, and G. Huang, "Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis, " Journal of Gastroenterology and Hepatology (Australia), vol. 25, no. 10, pp. 1604-1617, 2010.
29. C. Persson, P. Canedo, J. C. MacHado, E. M. El-Omar, and D. Forman, "Polymorphisms in inflammatory response genes and their association with gastric cancer: a HuGE systematic review and meta-analyses, " American Journal of Epidemiology, vol. 173, no. 3, pp. 259-270, 2011.
30. H. J. Kerkhof, M. Doherty, N. K. Arden et al., "Large-scalemetaanalysis of interleukin-1 and interleukin-1 receptor antagonist polymorphisms on risk of radiographic hip and knee osteoarthritis and severity of knee osteoarthritis, " Osteoarthritis and Cartilage, vol. 19, no. 3, pp. 265-271, 2011.
31. B. Peleteiro, N. Lunet, C. Carrilho et al., "Association between cytokine gene polymorphisms and gastric precancerous lesions: systematic review and meta-analysis, " Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 3, pp. 762-776, 2010.
32. V. D. Corleto, C. Pagnini, G. Margagnoni et al. IL-1-511 and IL-1RN2 polymorphisms in inflammatory bowel disease: an Italian population study and meta-analysis of European studies, " Digestive and Liver Disease, vol. 42, no. 3, 179-184, 2010.
33. I. Aksentijevich, S. L. Masters, P. J. Ferguson et al., "An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist, "The New England Journal of Medicine, vol. 360, no. 23, pp. 2426-2437, 2009.
34. N. M. Korthagen, C. H. M. van Moorsel, K. M. Kazemier, H. J. T. Ruven, and J. C. Grutters, "IL1RNgenetic variations and risk of IPF: a meta-analysis and mRNA expression study, " Immunogenetics, vol. 64, no. 5, pp. 371-377, 2012.
35. K. Chu, X. Zhou, and B. Y. Luo, "Cytokine gene polymorphisms and Parkinsons disease: a meta-analysis, " Canadian Journal of Neurological Sciences, vol. 39, no. 1, pp. 58-64, 2012.
36. W. Hur, M.-L. Cho, S. K. Yoon et al., "Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonistdeficient mice, " Immunology Letters, vol. 106, no. 2, pp. 154-162, 2006.
37. K. Isoda, T. Matsuki, H. Kondo, Y. Iwakura, and F. Ohsuzu, "Deficiency of interleukin-1 receptor antagonist induces aortic valve disease in BALB/cMice, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 4, pp. 708-715, 2010.
38. K. L. Phillips, N. Jordan-Mahy, M. J. Nicklin, and C. L. Le Maitre, "Interleukin-1 receptor antagonist deficient mice provide insights into pathogenesis of human intervertebral disc degeneration, " Annals of the Rheumatic Diseases, vol. 72, no. 11, pp. 1860-1867, 2013.
39. J. Petrasek, S. Bala, T. Csak et al., "IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice, " Journal of Clinical Investigation, vol. 122, no. 10, pp. 3476-3489, 2012.
40. E. Conrad, T. K. Resch, P. Gogesch et al., "Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in mice, " Hepatology, vol. 59, no. 4, pp. 1555-1563, 2014.
41. S. Herold, T. S. Tabar, H. Janen et al., "Exudate macrophages attenuate lung injury by the release of IL-1 receptor antagonist in gram-negative pneumonia, "The American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 10, pp. 1380-1390, 2011.
42. E. Somm, E. Henrichot, A. Pernin et al., "Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: Impact on adipogenesis, food intake, and energy expenditure, " Diabetes, vol. 54, no. 12, pp. 3503-3509, 2005.
43. T. Vijmasi, F. Y. T. Chen, Y. T. Chen, M. Gallup, and N. McNamara, "Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease, " Molecular Vision, vol. 19, pp. 1957-1965, 2013.
44. J. E. Sims andD. E. Smith, "TheIL-1 family: regulators of immunity, " Nature Reviews Immunology, vol. 10, no. 2, pp. 89-102, 2010.
45. J. E. Towne, B. R. Renshaw, J. Douangpanya et al., "Interleukin-(IL-36) ligands require processing for full agonist (IL-36, IL-36, and IL-36) or antagonist (IL-36Ra) activity, " The Journal of Biological Chemistry, vol. 286, no. 49, pp. 42594-42602, 2011.
46. S. Marrakchi, P. Guigue, B. R. Renshaw et al., "Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis, " The New England Journal of Medicine, vol. 365, no. 7, pp. 620-628, 2011.
47. M. Farooq, H. Nakai, A. Fujimoto et al., "Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis, " Human Mutation, vol. 34, no. 1, pp. 176-183, 2013.
48. K. Sugiura, T. Takeichi, M. Kono et al., "A novel IL36RN/IL1F5 homozygous nonsense mutation, p. Arg10X, in a Japanese patient with adult-onset generalized pustular psoriasis, " British Journal of Dermatology, vol. 167, no. 3, pp. 699-701, 2012.
49. N. Kanazawa, T. Nakamura, N. Mikita, and F. Furukawa, "Novel IL36RN mutation in a Japanese case of early onset generalized pustular psoriasis, " Journal of Dermatology, vol. 40, no. 9, pp. 749-751, 2013.
50. C. Costelloe, M. Watson, A. Murphy et al., "IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8, " Journal of Neurochemistry, vol. 105, no. 5, pp. 1960-1969, 2008.
51. D. Magne, G. Palmer, J. L. Barton et al., "The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes, " Arthritis Research andTherapy, vol. 8, no. 3, article R80, 2006.
52. F. L. van de Veerdonk and M. G. Netea, "New insights in the immunobiology of IL-1 familymembers, " Frontiers in Immunology, vol. 4, article 167, 2013.
53. C. Lamacchia, G. Palmer, E. Rodriguez et al., "The severity of experimental arthritis is independent of IL-36 receptor signaling, " Arthritis Research and Therapy, vol. 15, no. 2, article R38, 2013.
54. R. A. Ramadas, S. L. Ewart, Y. Iwakura, B. D. Medoff, and A. M. LeVine, "IL-36 exerts pro-inflammatory effects in the lungs of mice, " PLoS ONE, vol. 7, no. 9, Article ID e45784, 2012.
55. E. J. P. Van Asseldonk, R. Stienstra, T. B. Koenen et al., "The effect of the interleukin-1 cytokine family members IL-1F6 and IL-1F8 on adipocyte differentiation, " Obesity, vol. 18, no. 11, pp. 2234-2236, 2010.
56. J. Leonhardt, M. Stanulla, R. Von Wasielewski et al., "Gene expression profile of the infective murine model for biliary atresia, " Pediatric Surgery International, vol. 22, no. 1, pp. 84-89, 2006.
57. S. Burgler, N. Ouaked, C. Bassin et al., "Differentiation and functional analysis of human TH17 cells, " Journal of Allergy and Clinical Immunology, vol. 123, no. 3, pp. 588. e7-595. e7, 2009.
58. L. E. Harrington, R. D. Hatton, P. R. Mangan et al., "Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, " Nature Immunology, vol. 6, no. 11, pp. 1123-1132, 2005.
59. P. Rahman, S. Sun, L. Peddle et al., "Association between the interleukin-1 family gene cluster and psoriatic arthritis, " Arthritis and Rheumatism, vol. 54, no. 7, pp. 2321-2325, 2006.
60. C.-T. Chou, A. E. Timms, J. C. C. Wei, W. C. Tsai, B. P. Wordsworth, and M. A. Brown, "Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese, " Annals of the Rheumatic Diseases, vol. 65, no. 8, pp. 1106-1109, 2006.
61. Z. S. Guo, C. Li, Z. M. Lin et al., "Association of IL-1 gene complex members with ankylosing spondylitis in Chinese Han population, " International Journal of Immunogenetics, vol. 37, no. 1, pp. 33-37, 2010.
62. A. Dehghan, J. Dupuis, M. Barbalic et al., "Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels, " Circulation, vol. 123, no. 7, pp. 731-738, 2011.
63. P. Bowness, A. Ridley, J. Shaw et al., "Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis, " The Journal of Immunology, vol. 186, no. 4, pp. 2672-2680, 2011.
64. Y. Mei, F. Pan, J. Gao et al., "Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis, " Clinical Rheumatology, vol. 30, no. 2, pp. 269-273, 2011.
65. D. Wendling, "IL-23 and IL-17 in ankylosing spondylitis, " Rheumatology International, vol. 30, no. 11, p. 1547, 2010.
66. X. Wang, Z. Lin, Q. Wei, Y. Jiang, and J. Gu, "Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis, " Rheumatology International, vol. 29, no. 11, pp. 1343-1347, 2009.
67. C. Jandus, G. Bioley, J.-P. Rivals, J. Dudler, D. Speiser, and P. Romero, "Increased numbers of circulating polyfunctionalTh17 memory cells in patients with seronegative spondylarthritides, " Arthritis and Rheumatism, vol. 58, no. 8, pp. 2307-2317, 2008.
68. J. Leipe, M. Grunke, C. Dechant et al., "Role of Th17 cells in human autoimmune arthritis, " Arthritis & Rheumatism, vol. 62, no. 10, pp. 2876-2885, 2010.
69. M. S. Gresnigt, B. Rosler, C. W. M. Jacobs et al., "The IL-36 receptor pathway regulates Aspergillus fumigatus-induced Th1 andTh17 responses, " European Journal of Immunology, vol. 43, no. 2, pp. 416-426, 2013.
70. S. Vigne, G. Palmer, C. Lamacchia et al., "IL-36R ligands are potent regulators of dendritic and T cells, " Blood, vol. 118, no. 22, pp. 5813-5823, 2011.
71. S. Mutamba, A. Allison, Y. Mahida, P. Barrow, and N. Foster, "Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9, " European Journal of Immunology, vol. 42, no. 3, pp. 607-617, 2012.
72. S. Vigne, G. Palmer, P. Martin et al., "IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells, " Blood, vol. 120, no. 17, pp. 3478-3487, 2012.
73. C. A. Dinarello and J. W. M. van derMeer, "Treating inflammation by blocking interleukin-1 in humans, " Seminars in Immunology, vol. 25, no. 6, pp. 469-484, 2013.